Eagle Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Eagle Wealth Advisors's ABBV Position: Q3 2026 in Review
Eagle Wealth Advisors increased its AbbVie (ABBV) stake by 8.1% in Q3 2026, buying an estimated $27.2K and bringing the position to 1,421 shares worth $372K. The position accounts for 0.27% of the portfolio, ranked #71.
Eagle Wealth Advisors first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Eagle Wealth Advisors held 1,421 shares of AbbVie worth $372K as of Q3 2026.
- Eagle Wealth Advisors bought 106 AbbVie shares in Q3 2026, an estimated $27.2K.
- AbbVie made up 0.27% of Eagle Wealth Advisors's portfolio in Q3 2026, its #71 holding.
- Eagle Wealth Advisors first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
- 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Eagle Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.